Lucy E. Side
Impact in
- Genetics top 0.2%
- BRCA gene mutations in cancer
- Genetic Associations and Epidemiology
- Genomics and Rare Diseases
-
- Genetic factors in colorectal cancer
Papers in
- Genetics 102
- BRCA gene mutations in cancer 90
- Genomics and Rare Diseases 13
- Genetic Associations and Epidemiology 6
-
- Genetic factors in colorectal cancer 15
- Co-authors
- Sue Gessler (20 shared papers)KEVIN M. SHANNON (3 shared papers)Jane Wardle (14 shared papers)Anne Lanceley (13 shared papers)Patricia Thompson (2 shared papers)Brigit R. Taylor (2 shared papers)Belinda Rahman (9 shared papers)Lindsay Sarah Macduff Fraser (10 shared papers)
- Journals
- Journal of Medical Genetics (9 papers)BJOG An International Journal of Obstetrics & Gynaecology (7 papers)Nature Communications (7 papers)Genetics in Medicine (7 papers)JNCI Journal of the National Cancer Institute (6 papers)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Lucy E. Side
140 papers receiving 11.3k citations
Lucy E. Side's Hit Papers
Peers
Comparison fields: 5 of 137
- Genetics 5.5k
- Pathology and Forensic Medicine 951
- Oncology 1.2k
- Cancer Research 682
- Reproductive Medicine 473
Countries citing papers authored by Lucy E. Side
This map shows the geographic impact of Lucy E. Side's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy E. Side with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy E. Side more than expected).
Fields of papers citing papers by Lucy E. Side
This network shows the impact of papers produced by Lucy E. Side. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy E. Side. The network helps show where Lucy E. Side may publish in the future.
Co-authors
The 25 scholars most cited alongside Lucy E. Side, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 144 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial Hit paper breakdown → | 2011 | 781 |
| 2 | Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE Hit paper breakdown → | 2013 | 723 |
| 3 | Germline BRCA Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer Hit paper breakdown → | 2013 | 676 |
| 4 | Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1 / 2 (CIMBA) Hit paper breakdown → | 2012 | 538 |
| 5 | Whole-genome sequencing of patients with rare diseases in a national health system Hit paper breakdown → | 2020 | 418 |
| 6 | Evidence for 28 genetic disorders discovered by combining healthcare and research data Hit paper breakdown → | 2020 | 417 |
| 7 | Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer Hit paper breakdown → | 2017 | 368 |
| 8 | 2013 | 331 | |
| 9 | Cancer Risks Associated With GermlinePALB2Pathogenic Variants: An International Study of 524 Families Hit paper breakdown → | 2019 | 314 |
| 10 | Cancer prevention with aspirin in hereditary colorectal cancer (Lynch syndrome), 10-year follow-up and registry-based 20-year data in the CAPP2 study: a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2020 | 308 |
| 11 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer Hit paper breakdown → | 2017 | 306 |
| 12 | 2006 | 305 | |
| 13 | 2011 | 283 | |
| 14 | 2017 | 260 | |
| 15 | 2018 | 245 | |
| 16 | 1997 | 241 | |
| 17 | 2008 | 236 | |
| 18 | 2015 | 207 | |
| 19 | 2014 | 197 | |
| 20 | 2019 | 186 |
About Lucy E. Side
Lucy E. Side is a scholar working on Genetics, Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine, Hematology and Neurology, having authored 144 papers that have together received 11.6k indexed citations. Recurring topics across this work include BRCA gene mutations in cancer (90 papers), Genetic factors in colorectal cancer (15 papers), Genomics and Rare Diseases (13 papers), Prostate Cancer Diagnosis and Treatment (8 papers), Patient-Provider Communication in Healthcare (7 papers), Acute Myeloid Leukemia Research (6 papers), Neurofibromatosis and Schwannoma Cases (6 papers) and Genetic Associations and Epidemiology (6 papers). The work is most often cited by research in Genetics (5.5k citations), Pathology and Forensic Medicine (951 citations), Oncology (1.2k citations), Cancer Research (682 citations) and Reproductive Medicine (473 citations). Lucy E. Side has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Sue Gessler, KEVIN M. SHANNON, Jane Wardle, Anne Lanceley, Patricia Thompson, Brigit R. Taylor, Belinda Rahman, Lindsay Sarah Macduff Fraser, Saskia C. Sanderson and Samuel George Smith. Their work appears in journals such as Journal of Medical Genetics, BJOG An International Journal of Obstetrics & Gynaecology, Nature Communications, Genetics in Medicine and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.